Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis

Annals of Neurology

Volumn 43, Issue 1, 1998, Pages 15-24

  Archelos, Juan J ^a,d   Trotter, Jacqueline ^b   Previtali, Stefano ^a   Weißbrich, Benedikt ^a   Toyka, Klaus V ^a   Hartung, Hans Peter ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF GRAZ   (Austria)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; EPITOPE;

ADOLESCENT; ADULT; AGED; ALU SEQUENCE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; OPEN READING FRAME; PRIORITY JOURNAL; STEM CELL;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; AUTOANTIBODIES; B-LYMPHOCYTES; BASE SEQUENCE; CELL LINE, TRANSFORMED; EPITOPES; FEMALE; HUMANS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; OLIGODENDROGLIA; STEM CELLS;

EID: 0031890230     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410430107     Document Type: Article

References (39)

1. Lucchinetti CF, Rodriguez M. The controversy surrounding the pathogenesis of the multiple sclerosis lesion. Mayo Clin Proc 1997;72:813-895
2. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996; 85:299-302
3. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10: 153-187
4. Swanborg RH. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease. Clin Immunol Immunopathol 1995;77:4-13
5. Ludwin SK. The pathobiology of the oligodendrocyte. J Neuropathol Exp Neurol 1997;56:111-124
6. Prineas JW, Barnard RO, Kwon EE, et al. 1993. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33:137-151
7. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-274
8. Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 1993;68:627-636
9. Jung M, Krämer E, Grzenkowski M, et al. Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and in vivo. Eur J Neurosci 1995;7:1245-1265
10. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning - a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1990
11. Glover DM, Hames BD. DNA cloning: a practical approach. Oxford, UK: Oxford University Press, 1995
12. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
13. Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31-40
14. Archelos JJ, Roggenbuck K, Schneider-Schaulies J, et al. Detection and quantification of antibodies to the extracellular domain of PO during experimental allergic neuritis. J Neurol Sci 1993;117:197-205
15. Schnitzer J, Schachner M. Characterization of isolated mouse cerebellar cell populations in vitro. J Neuroimmunol 1981;1: 457-470
16. Dörries R, ter Meulen V. Detection and identification of virus-specific oligoclonal IgG in unconcentrated cerebrospinal fluid by immunoblot technique. J Neuroimmunol 1984;7:77-89
17. Margalit H, Nadir E, Ben-Sasson SA. A complete Alu element within the coding sequence of a central gene. Cell 1994;78: 173-174
18. Raine CS, Wu E, Ivanyi J, et al. Multiple sclerosis: a protective role or a pathogenic role for heat shock protein 60 in the central nervous system? Lab Invest 1996;75:109-123
19. Makalowski W, Mitchell GA, Labuda D. Alu sequences in the coding regions of mRNA: a source of protein variability. Trends Genet 1994;10:188-193
20. Chen J, Heerdt BG, Augenlicht LH. Presence and instability of repetitive elements in sequences the altered expression of which characterizes risk for colonic cancer. Cancer Res 1995;55:174-180
21. Panning B, Smiley JR. Activation of expression of multiple subfamilies of human Alu elements by adenovirus type 5 and herpes simplex virus type 1. J Mol Biol 1995;248:513-524
22. Hinks LJ, Price SE, Mason CR. Single strand conformation analysis of two genes contained within the first intron of the neurofibromatosis type I gene in patients with multiple sclerosis. Neuropathol Appl Neurobiol 1995;21:201-207
23. Shirashi M, Sekiya T. Mutations and an Alu repeated sequence associated with the DXS43 locus in human small cell lung cancer. Oncogene 1995;10:1453-1454
24. Nystföm-Lahti M, Kristo P, Nicolaides NC, et al. Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nat Med 1995;1:1203-1206
25. Tycko B, Smith SD, Sklar J. Chromosomal translocation joining LCK and TCRB loci in human T cell leukemia. J Exp Med 1991;174:867-873
26. Knebelmann B, Forestier L, Drouot L, et al. Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 1995; 4:675-679
27. Wallace MR, Andersen LB, Saulino AM, et al. A de novo Alu insertion results in neurofibromatosis type 1. Nature 1991;353: 864-866
28. Colombo E, Banki K, Tatum AH, et al. Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest 1997;99:1238-1250
29. Reynolds K, Zimmer AM, Zimmer A. Regulation of RARβ2 mRNA expression: evidence for an inhibitory peptide encoded in the 5′-untranslated region. J Cell Biol 1996;134:827-835
30. Kozak M. An analysis of vertebrate mRNA sequences: initiations of translational control. J Cell Biol 1991;115:887-903
31. Zeman AZJ, Keir G, Luxton R, Thompson EJ. Serum oligoclonal IgG is a common and persisting finding in multiple sclerosis, and has a systemic source. Q J Med 1996;89:187-193
32. Reichlin M. Cell injury mediated by autoantibodies to intracellular antigens. Clin Immunol Immunopathol 1995;76:215-219
33. Trotter JL, Cross AH. Autoantibodies in demyelinating disease. In: Cook SD, ed. Handbook of multiple sclerosis. 2nd ed. New York: Marcel Dekker, 1996:187-199
34. Tourtelotte WW, Tumani H. Multiple sclerosis cerebrospinal fluid. In: Raine CS, McFarland HF, Tourtellote WW, eds. Multiple sclerosis, clinical and pathogenetic basis. London: Chapman and Hall Medical, 1997:57-79
35. Link H. B cells and autoimmunity. In: Russell WC, ed. Molecular biology of multiple sclerosis. New York: John Wiley, 1997:161-190
36. Möller JR, Johnson D, Brady RO, et al. Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 1989;22:55-61
37. Warren KG, Catz I, Johnson E, Mielke B. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann Neurol 1994;35:280-289
38. Van Noort JM, van Sechel AC, Bajramovic JJ, et al. The small heat-shock protein ctB-crystallin as candidate autoantigen in multiple sclerosis. Nature 1995;375:798-801
39. Jones DB, Coulson AFW, Duff GW. Sequence homologies between hsp60 and autoantigens. Immunol Today 1993;14:115-118